FEI Announces NSAIDs Debate Process

12 years ago StraightArrow Comments Off on FEI Announces NSAIDs Debate Process

FEI logo

LAUSANNE, Switzerland, Mar. 9–The International Equestrian Federation (FEI) announced Tuesday the process for the debate on the use of non-steroidal anti-inflammatory drugs (NSAIDs) in competition leading to the introduction of a revised list in April, 2011.

After a meeting of the FEI Executive Board Tuesday, the FEI said that a central point in the debate will be the FEI Congress on NSAIDs Usage and Medication in the Equine Athlete to be held in Lausanne in August.

To lead the debate, the EB appointed an FEI Congress Committee chaired by 1st Vice President Sven Holmberg and composed of Chris Hodson (2nd Vice President), John McEwen (Chairman of FEI Veterinary Committee), Graeme Cooke (FEI Veterinary Director), Dr Yves Rossier, and Prof. Leo Jeffcott as members. The composition of the FEI List Group will be announced shortly.

The following timeline has been established:

– Mid-April – the science currently available published online

– Mid to end July – information will be distributed for consultation. It will reflect the policy issue of whether the FEI should allow the restricted use of NSAIDs, provided the levels are limited and are deemed by the List Group not to threaten horse welfare and not to be performance enhancing.

– August – congress held in Lausanne

– End of August – consultation with the National Federations begins with lists and Congress proceedings sent to NFs.

– Beginning of October – final Lists sent to NFs

– Beginning of November: FEI General Assembly votes on policy; FEI Bureau approves revised List

– April 2011 – Revised List comes into effect

To facilitate the debate, the FEI will set up in the coming weeks a virtual platform in which National Federations, riders, trainers, officials, event organizers, veterinarians, the media and the general public will be able to access the science currently available and will be encouraged to submit their contributions.